At the end of April, junior-year students of specialty G21 “Biotechnology and Bioengineering” had the opportunity to visit PrAT INDAR – an enterprise with a complete production cycle for manufacturing recombinant insulins – from raw material to finished pharmaceutical forms.
During the tour, we were acquainted with the history of the factory, learned about the structure of the enterprise, and studied the entire insulin production process, starting with the preparation of raw materials and ending with the packaging of the finished product, the maintenance of the cold chain from production to consumer, what data loggers are and what they are used for.
The company exports to many countries around the world, and INDAR also participates in humanitarian programs, conducting lectures and training, including educating patients themselves. In addition to their main products, they also produce auxiliary preparations that facilitate application. We were given detailed information about the stages of insulin production: fermentation, bulk substance preparation, refolding, purification and formulation of finished pharmaceutical forms, and filling of primary containers. We learned that there are several types of insulin: regular soluble insulin and isophane insulin (in the form of crystals). We were impressed by the impeccable organization of production and the use of advanced technologies that allow obtaining high-quality products with minimal health risks to people. Equipment qualification, validation of technological processes and computer systems was carried out in compliance with FDA requirements.
Since October 2000, the factory has been producing preparations under its own trade names: HUMODAR (recombinant human insulins), MONODAR (monocomponent porcine insulins), as well as preparations from other groups – anticoagulants (heparin) and hemostatic pharmaceutical agents (protamine sulfate).
Furthermore, it was interesting to learn about the product quality control process at each stage of production; for each step there is an instruction, and absolutely all actions are subject to documentation. The factory has proper certificates of compliance with international quality standards, such as ISO 9001 and ISO 13485. Additionally, the factory regularly undergoes inspections by relevant international quality control bodies, such as the FDA, EMA, and WHO, to ensure high quality of its products. We were inspired by the fact that the company ensures that each batch of insulin is tested and meets all quality standards, which is especially important for pharmaceutical products.
Below are the reviews of students who visited the tour:
Dolia Liubov BT-1-1: “Recently I had a unique opportunity to visit a tour at PrAT INDAR. I was extremely impressed by the enterprise with a complete production cycle for insulin manufacturing. This was an extremely interesting experience that gave me a lot of knowledge about insulin production processes. The tour was filled with interesting and fascinating information. Thank you for the opportunity to see the production of a medicine so important to humanity, one that saves thousands of lives!”
Latushkin Oleksiy BT-2-1: “We were fortunate to visit a tour at the enterprise for microbiological synthesis of insulin at PrAT INDAR and see firsthand one of the few companies engaged in biotechnology in Ukraine. We were shown the premises where insulin synthesis occurs using E. coli, its subsequent filtration, refolding (imparting the protein with the desired shape), purification and packaging, as well as the laboratory of physicochemical analysis. We were also given lectures on the history of the enterprise and company activities, as well as a brief overview of various departments and career guidance for those present. Overall, the tour was interesting and informative, allowing us to broaden our horizons regarding the labor market for biotechnologists and increased motivation to study, since working at this enterprise in many positions requires a large amount of theoretical and practical knowledge.”
Klymenko Maksym BT-1-1: “The tour to PrAT INDAR was 100% successful! I really enjoyed it! To familiarize ourselves with the production facilities, we were all provided with special protective uniforms to maintain sanitary standards. Then we were familiarized with the components of production: the preparation and obtaining of raw materials, verification of sensor and equipment readings, the process of producing the active substance of insulin from an E. coli bacterial strain on specific nutrient medium, purification and filtration of the active substance to 99% purity and preparation for filling ampoules with insulin followed by their marking and packaging. The tour was very intensive; three hours flew by quickly. Thank you very much to the organizers for the opportunity to see our future workplace!”
Samoilenko Viktoriia BT-1-1: “Recently we visited the pharmaceutical company INDAR, which specializes in the production of recombinant insulins.
At the beginning, we were told the brief history of the company and about the GMP standards they operate under. Then we were explained the insulin production cycle, from fermentation to packaging and logistics. And after familiarizing ourselves with the main aspects, we were allowed to see the process with our own eyes and were given a tour of the production facility, where we received answers to all the questions that interested us. This made it possible to better understand all the peculiarities of the processes necessary for insulin production.
Upon completion, we were impressed and happy that we could attend a tour at this wonderful pharmaceutical company. Not only did we learn a lot of new information about production, but we were also pleasantly impressed by how many employment opportunities are available for graduates of specialty G21 “Biotechnology and Bioengineering”.”
Sakhnevych Anastasiia BT-1-1: “To say that I am delighted is to say nothing. First of all, it was a very good experience. Every moment of the tour was positively saturated both emotionally and informatively (I especially liked the laboratories). What can be said about our wonderful “guides” who told us and showed us everything.”
Topikha Tetiana BT-1-1: “I am very satisfied that I participated in the tour at PrAT INDAR. From the moment of arrival at the enterprise premises, I felt a friendly atmosphere where all employees were very hospitable and ready to share their experience with us. During the tour, we had the opportunity to learn a lot of interesting things about insulin production. It was very impressive to see the high-tech equipment used to create high-quality products. Particularly memorable was visiting the production facilities and getting acquainted with the work process. Moreover, the tour was very well organized, conducted in a very clear and accessible way so that we could understand the production process.
Overall, I really enjoyed the tour at PrAT INDAR and recommend everyone to visit this enterprise.”
Graduate student of specialty G21 “Biotechnology and Bioengineering” Morsh Taisiia BT-1-2









